CAP
CAP
Abstract
Pneumonia is one of the most common diseases of modern medicine. It represents the inflammation of the lung parenchyma, caused by various toxins or agents. It is present in both sexes equally, but occurs more often in elderly people, immunocompromised people and people with comorbidities (COPD, cardiology, nephrology). The most common causes of pneumonia are Streptoccocus pneumonia, Haemophilus influenzae, Moraxella catarrhalis and Mycoplasma pneumoniae. Based on the clinical picture, laboratory analyses, sputum analysis, scores (CURB65 and PSI), outpatient or hospital treatment is decided. Treatment is pharmacological and non-pharmacological. Medical treatment is combined antibiotic therapy according to the antibiogram, but empiric treatment is significantly more common. The importance of this topic is in the appropriate and adequate treatment of these patients, considering the still high mortality rate in the world of patients with pneumonia.
References
1) Racionalna upotreba antibiotika – Nacionalni vodič dobre kliničke prakse, Republika
Srbija, Ministarstvo zdravlja, Beograd 2018. godine
2) Vanbolničke pneumonije kod odraslih pacijenata u primarnoj zdravstvenoj zaštiti:
dijagnostika i terapija – Nacionalne smjernice dobre kliničke prakse, Crna Gora,
Ministarstvo zdravlja, Podgorica 2020. godine.
3) Diagnosis and Tretment of Adults with Community-acquired Pneumonia – An official
Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases
Society of America, august 2019.
4) Pneumonia: The true story of the ֞ Winter Fever“
https://www.passporthealthusa.com/2015/08/pneumonia-history-and-prevention-of-
the-winter-fever/
5) National Institute for Health and Care Exellence. Pneumonia in adults: diagnosis and
management: Clinical guidelines; NICE; 2014
http://www.nice.org.uk/guidance/cg191/resources/pneumonia-in-adults-diagnosis-and-
management-pdf-35109868127173
6. Baralić M, Spasojević I, Miljuš G, Šunderić M, Robajac D, Dobrijević Z,
Gligorijević N, Nedić O, Penezić A. Albumin at the intersection between antioxidant
and pro-oxidant in patients on peritoneal dialysis. Free Radic Biol Med. 2022
Jul;187:105-112.
7. Baralić M, Gligorijević N, Brković V, Katrlík J, Pažitná L, Šunderić M, Miljuš G,
Penezić A, Dobrijević Z, Laušević M, Nedić O, Robajac D. Fibrinogen Fucosylation
as a Prognostic Marker of End-Stage Renal Disease in Patients on Peritoneal Dialysis.
Biomolecules. 2020 Aug 9;10(8):1165.
- Autori zadržavaju autorska prava i pružaju časopisu pravo prvog objavljivanja rada i licenciraju ga "Creative Commons Attribution licencom" koja omogućava drugima da dele rad, uz uslov navođenja autorstva i izvornog objavljivanja u ovom časopisu.
- Autori mogu izraditi zasebne, ugovorne aranžmane za neekskluzivnu distribuciju članka objavljenog u časopisu (npr. postavljanje u institucionalni repozitorijum ili objavljivanje u knjizi), uz navođenje da je članak izvorno objavljen u ovom časopisu.
- Autorima je dozvoljeno i podstiču se da postave objavljeni članak onlajn (npr. u institucionalni repozitorijum ili na svoju internet stranicu) pre ili tokom postupka prijave rukopisa, s obzirom da takav postupak može voditi produktivnoj razmeni ideja i ranijoj i većoj citiranosti objavljenog članka (Vidi Efekti otvorenog pristupa).